High versus low fixed-dose four factor-prothrombin complex concentrate for warfarin reversal in patients with intracranial hemorrhage-Reference-Cited by-同舟云学术

High versus low fixed-dose four factor-prothrombin complex concentrate for warfarin reversal in patients with intracranial hemorrhage

Published:2022-10 Issue:5 Volume:61 Page:103444
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Compton Frances,Hall Jeremy,De Simone Nicole,Usmani Amena,Sarode Ravi,Burner James

Publisher

Elsevier BV

Subject

Hematology

Reference12 articles.

1. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition);Schulman;Chest,2008

2. Four factor prothrombin complex concentrate (human): review of the pharmacology and clinical application for vitamin K antagonist reversal;Kinard;Expert Rev Cardiovasc Ther,2014

3. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal: a systematic review and meta-analysis;Chai-Adisaksopha;Thromb Haemost,2016

4. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition);Ansell;Chest,2008

5. Efficacy and safety of four-factor prothrombin complex concentrate (4F-PCC) in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma controlled, phase IIIb study;Sarode;Circulation,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Analysis of the Real-World Utilization of 4-Factor Prothrombin Complex Concentrate and Plasma in Oral Anticoagulant-Associated Bleeding in US Hospitals;Clinical and Applied Thrombosis/Hemostasis;2023-01